Best Immunotherapy Treatment Hospitals Worldwide

At Manipal Hospital, Gurugram, Immunotherapy is delivered through individualized oncology treatment plans and modern diagnostic and therapeutic facilities. Established in 2008, the NABL, NABH accredited hospital in Gurgaon, India has 380 beds and provides comprehensive cancer care.

Immunotherapy is a form of cancer treatment designed to stimulate or enhance the immune system's ability to fight malignant cells. It may be used alone or combined with treatments such as chemotherapy, radiation therapy, targeted therapy, or surgery, depending on the patient's diagnosis. Treatment is selected according to factors such as cancer type, stage, molecular characteristics, and previous therapies. Regular clinical assessments and laboratory tests help monitor response and safety.

Manipal Hospitals Goa, Dona Paula provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 1994, the NABH accredited hospital is based in Panjim, India and has 235 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

Choosing Fortis Hospital for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 2006, the JCI, NABH accredited hospital is located in Mohali, India and operates 276 beds with modern oncology infrastructure.

Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.

Choosing Manipal Hospital, Hebbal for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 1991, the NABL, NABH accredited hospital is located in Bangalore, India and operates 280 beds with modern oncology infrastructure.

Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.

American Oncology Institute provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2013, the NABH accredited hospital is based in Hyderabad, India and has 150 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

At Asian Institute of Medical Sciences, Immunotherapy is delivered through individualized oncology treatment plans and modern diagnostic and therapeutic facilities. Established in 2010, the NABL, NABH accredited hospital in Faridabad, India has 425 beds and provides comprehensive cancer care.

Immunotherapy is a form of cancer treatment designed to stimulate or enhance the immune system's ability to fight malignant cells. It may be used alone or combined with treatments such as chemotherapy, radiation therapy, targeted therapy, or surgery, depending on the patient's diagnosis. Treatment is selected according to factors such as cancer type, stage, molecular characteristics, and previous therapies. Regular clinical assessments and laboratory tests help monitor response and safety.

Fortis Hospital, Mulund provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 2002, the JCI, NABH accredited hospital is located in Mumbai, India and operates 315 beds with advanced oncology and infusion-care facilities.

Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.

At Max Super Speciality Hospital, Saket, Immunotherapy is delivered through individualized oncology treatment plans and modern diagnostic and therapeutic facilities. Established in 2006, the JCI, NABH accredited hospital in Delhi, India has 539 beds and provides comprehensive cancer care.

Immunotherapy is a form of cancer treatment designed to stimulate or enhance the immune system's ability to fight malignant cells. It may be used alone or combined with treatments such as chemotherapy, radiation therapy, targeted therapy, or surgery, depending on the patient's diagnosis. Treatment is selected according to factors such as cancer type, stage, molecular characteristics, and previous therapies. Regular clinical assessments and laboratory tests help monitor response and safety.

Fortis Memorial Research Institute provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2013, the JCI, NABH, NABL accredited hospital is based in Gurgaon, India and has 311 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

Riyadh Care Hospital offers specialized Immunotherapy supported by experienced oncology specialists, advanced treatment technology, and structured patient monitoring. Established in 1990, the JCI accredited hospital is situated in Riyadh, Saudi Arabia and has 325 beds with comprehensive cancer treatment infrastructure.

Immunotherapy may be recommended for selected patients when the cancer has specific characteristics that make it responsive to immune-based treatment. Certain medicines work by removing inhibitory signals that prevent immune cells from attacking cancer, while others target specific immune pathways or cancer-associated proteins. Treatment is usually administered according to a planned schedule, with patients monitored for fatigue, skin reactions, inflammation, and other potential immune-related effects.

Taoufik Clinique provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 1979, the ISO accredited hospital is based in Tunis, Tunisia and has 180 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

At Baskent University Istanbul Hospital, Immunotherapy is delivered through individualized oncology treatment plans and modern diagnostic and therapeutic facilities. Established in 1993, the JCI, ISO accredited hospital in Istanbul, Turkey has 144 beds and provides comprehensive cancer care.

Immunotherapy is a form of cancer treatment designed to stimulate or enhance the immune system's ability to fight malignant cells. It may be used alone or combined with treatments such as chemotherapy, radiation therapy, targeted therapy, or surgery, depending on the patient's diagnosis. Treatment is selected according to factors such as cancer type, stage, molecular characteristics, and previous therapies. Regular clinical assessments and laboratory tests help monitor response and safety.

Hospital Ruber International provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 1982, the ISO accredited hospital is based in Madrid, Spain and has 345 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

At Paracelsus Clinic, Immunotherapy is delivered through individualized oncology treatment plans and modern diagnostic and therapeutic facilities. Established in 1953, the accredited hospital in Lustmuhle, Switzerland has 95 beds and provides comprehensive cancer care.

Immunotherapy is a form of cancer treatment designed to stimulate or enhance the immune system's ability to fight malignant cells. It may be used alone or combined with treatments such as chemotherapy, radiation therapy, targeted therapy, or surgery, depending on the patient's diagnosis. Treatment is selected according to factors such as cancer type, stage, molecular characteristics, and previous therapies. Regular clinical assessments and laboratory tests help monitor response and safety.

The Madras Institute of Orthopedics and Traumatology offers specialized Immunotherapy supported by experienced oncology specialists, advanced treatment technology, and structured patient monitoring. Established in 1999, the JCI, NABH accredited hospital is situated in Chennai, India and has 1000 beds with comprehensive cancer treatment infrastructure.

Immunotherapy may be recommended for selected patients when the cancer has specific characteristics that make it responsive to immune-based treatment. Certain medicines work by removing inhibitory signals that prevent immune cells from attacking cancer, while others target specific immune pathways or cancer-associated proteins. Treatment is usually administered according to a planned schedule, with patients monitored for fatigue, skin reactions, inflammation, and other potential immune-related effects.